SCIENCE@home

Harnessing personalized tailored medicines to digital-based data-enriched edible pharmaceuticals.

Mayank Handa,O. Afzal,S. Beg,Sachin SanapNasik,R. Kaundal,R. Verma,AwanishMishra,R. Shukla

Published 2023 in Drug Discovery Today

ABSTRACT

Tailoring drug products to personalized medicines poses challenges for conventional dosage forms. The prominent reason is the restricted availability of flexible dosage strengths in the market. Inappropriate dosage strengths lead to adverse drug reactions or compromised therapeutic effects. The situation worsens when the drug has a narrow therapeutic window. To overcome these challenges, data-enriched edible pharmaceuticals (DEEP) are novel concepts for designing solid oral products. DEEP have individualized doses and information embedded in quick response (QR) code form. When data are presented in a QR code, the information is printed with edible ink that contains the drug in tailored doses required for the patients. Teaser: Digital-based data-enriched edible pharmaceuticals marketed as new and personalized drug delivery systems that cater the need of all age group of patients.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-75 of 75 references · Page 1 of 1

CITED BY